United States · FDA National Drug Code directory
Cyclobenzaprine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-5711_22a3e440-266d-4a3e-a1fe-6df83fea6abd
- Product NDC
- 50090-5711
- Form
- TABLET, FILM COATED
- Composition / generic term
- Cyclobenzaprine hydrochloride
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200706
- Source listing expiry
- 20261231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 15 TABLET, FILM COATED in 1 BOTTLE (50090-5711-0) · 50090-5711-0
- 20 TABLET, FILM COATED in 1 BOTTLE (50090-5711-1) · 50090-5711-1
- 30 TABLET, FILM COATED in 1 BOTTLE (50090-5711-2) · 50090-5711-2
- 60 TABLET, FILM COATED in 1 BOTTLE (50090-5711-3) · 50090-5711-3
- 100 TABLET, FILM COATED in 1 BOTTLE (50090-5711-4) · 50090-5711-4
- 7 TABLET, FILM COATED in 1 BOTTLE (50090-5711-6) · 50090-5711-6
- 14 TABLET, FILM COATED in 1 BOTTLE (50090-5711-7) · 50090-5711-7
- 21 TABLET, FILM COATED in 1 BOTTLE (50090-5711-8) · 50090-5711-8
- 10 TABLET, FILM COATED in 1 BOTTLE (50090-5711-9) · 50090-5711-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →